Torsten Kucharzik

Active 1995–2025

85
Papers
21,261
Citations
64
h-index
83
i10-index

Citations

Citations per year for Torsten Kucharzik1991: 1 citations1994: 4 citations1997: 3 citations1998: 5 citations1999: 4 citations2000: 16 citations2001: 21 citations2002: 31 citations2003: 48 citations2004: 85 citations2005: 92 citations2006: 101 citations2007: 72 citations2008: 86 citations2009: 85 citations2010: 81 citations2011: 67 citations2012: 58 citations2013: 62 citations2014: 63 citations2015: 81 citations2016: 99 citations2017: 106 citations2018: 132 citations2019: 553 citations2020: 732 citations2021: 769 citations2022: 786 citations2023: 748 citations2024: 1,268 citations2025: 541 citations2026: 9 citations1992–1993: no citations, so these years are not shown1995–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,366 citing papers, 15.6% of this breakdownItaly: 770 citing papers, 8.8% of this breakdownChina: 738 citing papers, 8.4% of this breakdownUnited Kingdom: 604 citing papers, 6.9% of this breakdownGermany: 570 citing papers, 6.5% of this breakdownFrance: 421 citing papers, 4.8% of this breakdownCanada: 411 citing papers, 4.7% of this breakdownSpain: 341 citing papers, 3.9% of this breakdownNetherlands: 309 citing papers, 3.5% of this breakdownJapan: 251 citing papers, 2.9% of this breakdownBelgium: 248 citing papers, 2.8% of this breakdownAustralia: 195 citing papers, 2.2% of this breakdown
0%15.6%Other 29%

Fields

  • Biochemistry, Genetics and Molecular Biology55%
  • Medicine26.7%
  • Immunology and Microbiology8.2%
  • Neuroscience4.3%
  • Nursing2.1%
  • Agricultural and Biological Sciences1.3%
  • Other2.4%

Topics

  • Inflammatory Bowel Disease19.4%
  • Microscopic Colitis6.6%
  • Gut microbiota and health4%
  • Autoimmune and Inflammatory Disorders2.6%
  • Rheumatoid Arthritis Research and Therapies2.1%
  • Barrier Structure and Function Studies1.9%
  • Other63.4%

Coauthors

All papers

Open in search
  1. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2018 cited by 1,822

  2. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesco Selvaggi, Bram Verstockt, Antonino Spinelli, Yves Panís, Glen Doherty - Journal of Crohn s and Colitis 2021 cited by 1,023

  3. ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Maaser, Fernando Magro, John K. Marshall, Pär Myrelid, Gianluca Pellino, Isadora Rosa, João Sabino, Edoardo Savarino, Antonino Spinelli, Laurents Stassen, Mathieu Uzzan, Stephan R. Vavricka, Bram Verstockt, Janindra Warusavitarne, Oded Zmora, Gionata Fiorino - Journal of Crohn s and Colitis 2019 cited by 1,344

  4. ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Torsten Kucharzik, Theodore Lytras, Christian Maaser, Fernando Magro, John K. Marshall, Pär Myrelid, Gianluca Pellino, Isadora Rosa, João Sabino, Edoardo Savarino, Laurents Stassen, Joana Torres, Mathieu Uzzan, Stephan R. Vavricka, Bram Verstockt, Oded Zmora - Journal of Crohn s and Colitis 2019 cited by 1,117

  5. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesco Selvaggi, Bram Verstockt, Glen Doherty, Tim Raine, Yves Panís - Journal of Crohn s and Colitis 2021 cited by 528

  6. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2016 cited by 2,071

  7. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

    Authors: , , , , , , , , , , , , - Journal of Crohn s and Colitis 2017 cited by 1,164

  8. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2021 cited by 452

  9. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2018 cited by 453

  10. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2023 cited by 273

  11. Ulcerative Colitis—Diagnostic and Therapeutic Algorithms

    Authors: , , , - Deutsches Ärzteblatt international 2020 cited by 260

  12. Expert Consensus on Optimal Acquisition and Development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: A Reliability and Inter-rater Variability Study on Intestinal Ultrasonography in Crohn’s Disease

    Authors: , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2020 cited by 220

  13. Defining Transabdominal Intestinal Ultrasound Treatment Response and Remission in Inflammatory Bowel Disease: Systematic Review and Expert Consensus Statement

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2021 cited by 164

  14. Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alberto Signore, Damian Tolan, Jeroen A. W. Tielbeek, Dominik Weishaupt, Bart M. Wiarda, Andrea Laghi - Journal of Crohn s and Colitis 2013 cited by 663

  15. Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gustav From, Miroslav Fedurco, Milos Gregus, Yoram Bouhnik, Andreas Luegering, Rocco Cosintino, Ivan Bunganic, Jaime Ramos, Mariam Aguas Peris, Olivier Dewit, Mariabeatrice Principi, Emma Wesley, Paula Lago, Stephane Nancey, María Dolores Martín Arranz, Pieter Hindryckx, Ambrogio Orlando, Andrea Geccherle, Maria Laura Annunziata, Bu'hussain Hayee, Jozef Balaz, Francisco Portela, Cyrielle Gilletta, Torsten Kucharzik, Miguel Mínguez, Javier Pérez Gisbert, Ana Gutiérrez Casbas, Edouard Louis, Marco Marino, Gareth Parkes, Fraser Cummings, Bindia Jharap, Jens Kjeldsen, Luís Correia, Paula Ministro, Matthias Ebert, Erik Hertervig, Dirk Staessen, Joris Dutré, Arnaud Colard, Graham Morrison, Henning Glerup, Jens Frederik Dahlerup, Frank Wolfhagen, Marian Batovsky, Martin Molnar, Barbora Kadleckova, Paulo Caldeira, David Laharie, Xavier Hebuterne, Bruno Bonaz, Matthieu Allez, Andreas Fischer, Joaquín Ernesto Hinojosa Del Val, Miriam Mañosa Ciria, Jose Manuel Herrera Justiniano, Charlotte Soderman, Rajiv Chandy, Craig Mowat, Peter Irving, Jan Fallingborg, Jan Matous, Tomas Douda, Romain Altwegg, Jose Manuel Benitez, María Teresa Arroyo Villarino, Jordi Guardiola Capón, Daniel Ginard Vicenc, Pieter Dewint, Sven Almer and 1 more - ˜The œLancet. Gastroenterology & hepatology 2022 cited by 127

  16. Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study

    Authors: , , , , , , , - Gut 2019 cited by 198

  17. ECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in Inflammatory Bowel Disease

    Authors: , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2021 cited by 140

  18. Recent advances in clinical practice: advances in cross-sectional imaging in inflammatory bowel disease

    Authors: , , , , - Gut 2022 cited by 139

  19. Early Ultrasound Response and Progressive Transmural Remission After Treatment With Ustekinumab in Crohn’s Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrej Potthoff, Wolfgang Reindl, Karolin Schliwa, Martin Schulz, H Schulze, Marco Affronti, Maria Laura, Christina Bezzio, Flaminia Cavallaro, Marina Coletta, Andrea Costantino, Federico Furfaro, Fabrizio Pizzolante, Steven Bots, Robert J. de Knegt, Ivan Bunganič, Zdenek Opravil, Joaquin Poza, Jordi Rimola, Cristina Suárez Ferrer - Clinical Gastroenterology and Hepatology 2022 cited by 97

  20. Use of Intestinal Ultrasound to Monitor Crohn’s Disease Activity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Torsten Kucharzik, Christian Maaser, Ulf Helwig, Volker Meister, Stefan Mielck, D Ludwig, Norbert Börner, Stefan Schanz, R Kihn, Robert M. Hoffmann, B Lányi, Robert Ehehalt, Burghard Wilborn, Franz Ludwig Dumoulin, Wolfgang Mohl, Andreas Lügering, Thomas Krummenerl, Jan Heidemann, Matthias Pichler, Hans D. Allescher, Frank Meyer-Hilse, G Franke, Oliver Bachmann, M Fähndrich - Clinical Gastroenterology and Hepatology 2016 cited by 246

  21. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter Bossuyt, Olivier Dewit, Geert D’Haens, Denis Franchimont, Édouard Louis, Séverine Vermeire, Çharles N. Bernstein, Raymond Bourdages, Naoki Chiba, Sonny S. Dhalla, Brian G. Feagan, Richard N. Fedorak, Jean-René Lachance, Remo Panaccione, Mark J. Ropeleski, B Salh, M Lukas, J.F. Colombel, Matthieu Allez, Pierre Desreumaux, Jean Louis Dupas, J.C. Grimaud, Xavier Hébuterne, David Laharie, Éric Lerebours, Laurent Peyrin‐Biroulet, J.M. Reimund, Stéphanie Viennot, Frank Zerbib, Castells Antoni, Raja Atreya, Daniel C. Baumgart, Christoph Berg, Ulrich Boecker, G. Bramkamp, C. Bünning, Robert Ehehalt, S Howaldt, Torsten Kucharzik, Hein Lamprecht, Jonas Mudter, J. Preiß, Stefan Schreiber, Ursula Seidler, I Altorjay, János Banai, Péter L. Lakatos, Márta Varga, Áron Vincze, Irit Avni‐Biron, Sigal Fishman, Gerald Fraser, Ehud Goldin, Daniel Rachmilewitz, Vito Annese, Sandro Ardizzone, Livia Biancone, Fabrizio Bossa, Silvio Danese, Walter Fries, Paolo Gionchetti, Giovanni Maconi, Giovanni Terrosu, P. Usai, Geert D’Haens, Richard B. Gearry, Jeffrey Hill, David Rowbotham, Michael Schultz, R.S. Stubbs and 56 more - Gastroenterology 2016 cited by 329

  22. CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonino Spinelli, A. Hillary Steinhart, Simon Travis, C. Janneke van der Woude, Bruce Yacyshyn, Takayuki Yamamoto, Matthieu Allez, Willem A. Bemelman, Amy L. Lightner, Édouard Louis, David T. Rubin, Ellen Scherl, Corey A. Siegel, Mark S. Silverberg, Séverine Vermeire, Claire E. Parker, Stefanie C. McFarlane, Leonardo Guizzetti, Michelle I. Smith, Niels Vande Casteele, Brian G. Feagan, Vipul Jairath - Gastroenterology 2022 cited by 79

  23. European evidence based consensus for endoscopy in inflammatory bowel disease

    Authors: , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2013 cited by 808

  24. Neutrophil Transmigration in Inflammatory Bowel Disease Is Associated with Differential Expression of Epithelial Intercellular Junction Proteins

    Authors: , , , , - American Journal Of Pathology 2001 cited by 516